Select Publications
Journal articles
2021, 'Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia', Journal of Viral Hepatitis, 28, pp. 1738 - 1743, http://dx.doi.org/10.1111/jvh.13612
,2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379
,2021, '“It's time!”: A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103280
,2021, 'Australian health and medical workers’ concerns around providing care to people living with hepatitis B', Health and Social Care in the Community, 29, pp. e431 - e439, http://dx.doi.org/10.1111/hsc.13368
,2021, 'Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103323
,2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477
,2021, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in SMART recovery mutual support groups: Stage 1 mixed methods pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/25217
,2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421
,2021, 'Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103292
,2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469
,2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261
,2021, 'Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex', International Journal of Drug Policy, 94, pp. 103229, http://dx.doi.org/10.1016/j.drugpo.2021.103229
,2021, 'Beyond deficit: ‘strengths-based approaches’ in Indigenous health research', Sociology of Health and Illness, 43, pp. 1405 - 1421, http://dx.doi.org/10.1111/1467-9566.13311
,2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7
,2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571
,2021, '‘I Wouldn’t call the cops if i was being bashed to death’: Sex work, whore stigma and the criminal legal system', International Journal for Crime, Justice and Social Democracy, 10, http://dx.doi.org/10.5204/IJCJSD.1894
,2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277
,2021, 'Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex.', Int J Drug Policy, 93, pp. 103163 - 103163, http://dx.doi.org/10.1016/j.drugpo.2021.103163
,2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, 87, pp. 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014
,2021, 'People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?', Addiction Research and Theory, 29, pp. 247 - 254, http://dx.doi.org/10.1080/16066359.2021.1879058
,2021, 'Rethinking the relationship between sex work, mental health and stigma: a qualitative study of sex workers in Australia', Social Science and Medicine, 268, http://dx.doi.org/10.1016/j.socscimed.2020.113468
,2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, 86, http://dx.doi.org/10.1016/j.drugpo.2020.102964
,2020, 'Identifying risk and protective factors, including culture and identity, for methamphetamine use in Aboriginal and Torres Strait Islander communities: Relevance of the ‘communities that care’ model', Social Science and Medicine, 266, http://dx.doi.org/10.1016/j.socscimed.2020.113451
,2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106
,2020, 'HIV stigma by association among Australian gay and bisexual men.', AIDS, 34 Suppl 1, pp. S53 - S62, http://dx.doi.org/10.1097/QAD.0000000000002565
,2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085
,2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, 73, pp. S127 - S127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587000206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389
,2020, 'The role of social support in moderating the relationship between HIV centrality, internalised stigma and psychological distress for people living with HIV', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 32, pp. 850 - 857, http://dx.doi.org/10.1080/09540121.2019.1659914
,2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15113
,2020, 'Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use', International Journal of Drug Policy, 78, pp. 102697, http://dx.doi.org/10.1016/j.drugpo.2020.102697
,2020, 'Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population', PLoS ONE, 15, pp. e0232218, http://dx.doi.org/10.1371/journal.pone.0232218
,2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225
,2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
,2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
,2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536
,2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144
,2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy, 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170
,2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705
,2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004
,2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698
,2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
,2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016
,2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002
,2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, 16, http://dx.doi.org/10.1186/s12954-019-0325-3
,2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112
,2019, 'Feasibility of a Mobile Health App for Routine Outcome Monitoring and Feedback in Mutual Support Groups Coordinated by SMART Recovery Australia: Protocol for a Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15113
,2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475
,2019, 'Predictors of health care workers’ support for discriminatory treatment and care of people who inject drugs', Psychology, Health and Medicine, 24, pp. 439 - 445, http://dx.doi.org/10.1080/13548506.2018.1546018
,2019, 'Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs', Patient, 12, pp. 259 - 265, http://dx.doi.org/10.1007/s40271-018-0332-6
,